US-based pharmaceutical giant McKesson is setting up a service center in Vilnius.
© DELFI / Domantas Pipas

According to information from the Center of Registers, McKesson Business Services Lithuania was registered on Wednesday with an authorized share capital of 5 million euros and Ildiko By as its CEO.

The new company is wholly owned by McKesson's European unit, Germany-registered McKesson Europe Holdings.

McKesson, one of the largest pharmaceutical businesses in the US, ranked 13th among the world's largest companies by 2018 revenue, next to Apple, Glencore, Samsung and others.

McKesson posted 208.4 billion US dollars in revenue for the 2017-2018 financial year, up 5 percent from 198.5 billion dollars a year earlier.

BNS

Swedbank's pension funds invest EUR 200 mln into sustainable business

Pension funds managed by the Swedbank financial group are investing 200 million euros, or a sixth...

Belarus complains: Lithuania's blocking Minsk-EU agreement

Belarusian representatives complained in Brussels last week that Lithuania is blocking the...

New trends in startup world: unicorns' aspiration is not key anymore

The question when the first unicorn with over 1 billion of US dollars in value will appear in the...

Shopping frenzy: biggest retail chains plans allocate millions of euros for new stores

Lithuania's five biggest retail chains – Maxima , Lidl , Rimi, Iki and Norfa – have...

Construction launched on EUR 15 mln hotel in Kaunas

Construction is being launched on a 15-million-euro Moxy hotel, part of the Marriott Group , in...